Providing novel treatments and standardising CLL biomarker testing across the world
Do immunoglobulin receptor interactions play a role in CLL?
Overcoming the shortfalls of ibrutinib with fludarabine in CLL patientss
TAP funded Tier study for relapsed and refractory CNS lymphoma patients
How the removal of macrophages from tissue can stop or slow down the progression of CLL